3,813 companies
10,015 AI summaries
7,617 risk analyses
3,719 growth scores
Register free — watchlist & alerts →
🔔 Get free email alerts on KANTO DENKA KOGYO CO.,LTD. (4047)
AI summaries of Japanese EDINET filings — in English. Free, unsubscribe anytime.
- ✓ Email alert when 4047 files its next EDINET disclosure
- ✓ AI summary · sentiment · risk · growth (JA / EN)
- ✓ Free account: watchlist & alerts on all the stocks you follow
EDINET 4047 Out of Scope
KANTO DENKA KOGYO CO.,LTD.
Change Report ／ 2026-08-24 15:49
Covers EDINET statutory filings (TDNET timely disclosures / earnings flashes are not included).
📊 Large-shareholding (5%) report Activist (proposals)
Holder: Effissimo Capital Management Pte Ltd
Stake: 19.83%
Change: 0pp increase
Purpose:
To invest and provide advice to management and make important proposals as circumstances warrant. The filer engages in engagement (constructive dialogue based on the Japan Stewardship Code) with the aim of improving corporate value over the medium to long term. For example, the filer has made or is expected to make proposals to the issuer regarding matters under Article 14-8-2, Paragraph 1, Items 5 and 12 of the Cabinet Order on the Financial Instruments and Exchange Act, and Article 16, Item 1 of the Cabinet Office Ordinance on Disclosure of Large Share Holdings. However, such proposals may n
🧩 5% holders of this company (2 holders · 26.03%)
| Holder | Stake | Change | |
|---|---|---|---|
| Effissimo Capital Management Pte Ltd Activist | 19.83% | 0pp | view |
| 朝日生命保険相互会社 Pure | 6.20% | 0pp | view |
Each holder’s most recent 5% filing. The sum reflects disclosed major-holder ownership, not total float.
Risk and growth scores and tags are AI-generated estimates from analyzing the disclosure. They are not guarantees of fact, nor investment advice or recommendations. Make investment decisions at your own discretion.
Track Japanese disclosures with JSIGNAL
AI summaries, risk & growth analysis, watchlist alerts and a screener for every Japanese listed company.
Start free — 30-day trial Login